UNSPSC 51273907: Benzalkonium chloride/benzocaine/dibucaine/tetracaine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE700. This VA Drug Class (DE700) classifies this compound as belonging to the group LOCAL ANESTHETICS, TOPICAL.

UNSPSC 51273907 Benzalkonium chloride/benzocaine/dibucaine/tetracaine is a Commodity code that does not align with recent state and local procurement activity under this designation. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and drug deactivation systems, products outside the scope of local anesthetics and topical pharmaceutical compounds that the code nominally describes. The mismatch suggests either a tagging error in the source data or that this code sees little genuine activity in state and local government procurement at present.

Seminole County's IFB, posted June 30, 2026 with a response deadline of July 26, 2023, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement requires vendors to submit bids electronically, include shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace certification. The contract is structured as a two-year initial term with a one-year renewal option, subject to a three-month probationary period, and is potentially FEMA-funded. Based on the single opportunity identified, the code shows limited recent state and local procurement activity under its stated commodity classification.